Hair Thinning & Hair Loss
Hair loss is progressive, but it is also one of the most treatable conditions in medicine. The key is starting before the follicles go dormant permanently.
Understanding hair loss
Androgenetic alopecia, commonly known as pattern hair loss, affects approximately 50 million men and 30 million women in the United States. It is the most common cause of hair thinning and is driven primarily by the hormone dihydrotestosterone (DHT), a potent androgen derived from testosterone. DHT binds to receptors in genetically susceptible hair follicles, causing them to shrink progressively with each growth cycle until they eventually stop producing visible hair.
In men, pattern hair loss typically begins with recession at the temples and thinning at the crown, eventually progressing to varying degrees of baldness. In women, the pattern is usually diffuse thinning across the top of the scalp with preservation of the frontal hairline. The process is gradual, often spanning years or decades, which is both a curse (you may not notice until significant loss has occurred) and an opportunity (early intervention can preserve substantially more hair than waiting).
The critical fact about hair loss is that it is far easier to maintain existing hair than to regrow hair from dormant follicles. Once a follicle has been miniaturized for long enough, it may lose its capacity to produce a full terminal hair. This is why dermatologists and hair restoration specialists consistently emphasize early treatment. The sooner you intervene, the more hair you keep.
What causes hair loss
DHT sensitivity
Genetically susceptible follicles shrink in response to DHT, producing progressively finer, shorter hairs until the follicle goes dormant. This is the primary driver of pattern hair loss.
Hormonal changes
Thyroid dysfunction, polycystic ovary syndrome, menopause, and postpartum hormonal shifts can trigger or accelerate hair thinning beyond genetic pattern loss.
Nutritional deficiency
Iron, zinc, biotin, vitamin D, and protein deficiencies impair the hair growth cycle. Restrictive diets and malabsorption are common culprits.
Stress-related shedding
Telogen effluvium, triggered by physical or emotional stress, illness, or surgery, pushes large numbers of follicles into the resting phase simultaneously, causing diffuse thinning 2-3 months after the triggering event.
How we treat hair loss
INA's hair loss protocols use the two most clinically validated approaches: DHT blocking and growth stimulation. Finasteride blocks the enzyme (5-alpha reductase) that converts testosterone to DHT, reducing scalp DHT levels by approximately 70% and halting the miniaturization process. Dutasteride offers stronger DHT suppression for patients with more advanced loss or those who have not responded adequately to finasteride. Minoxidil stimulates blood flow to the hair follicle and extends the growth phase of the hair cycle, promoting regrowth of thicker, longer hairs.
Our Custom Hair Kit combines these approaches for maximum efficacy. Your INA physician evaluates your hair loss pattern, severity, duration, and medical history to determine the optimal combination and dosing. For patients early in the process, finasteride alone may be sufficient. For those with more advanced thinning, a multi-mechanism approach produces the best outcomes. Consistent treatment is essential: most patients see visible improvement within 3-6 months, with full results at 12 months.
Recommended treatments
Frequently asked questions
How soon will I see results?
Will I lose hair if I stop treatment?
What are the side effects of finasteride?
Is dutasteride stronger than finasteride?
Can women use these medications?
Does minoxidil actually regrow hair?
Ready to address your hair thinning & hair loss?
Take our 5-minute health assessment. A board-certified physician will review your symptoms and customize a treatment protocol designed specifically for you.
Start your hair regrowth planMedical disclaimer
The information provided on this page is for educational purposes only and does not constitute medical advice. All treatments require a physician consultation and prescription. Individual results vary. Treatment eligibility is determined by a licensed healthcare provider based on your medical history and current health status. Do not start, stop, or change any medication without consulting your physician.
Warning: Compounded GLP-1s (Tirzepatide & Semaglutide)
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
- Severe nausea and/or vomiting resulting in dehydration - it is important to stay well hydrated and drink plenty of fluids while on this medication. Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis.
- Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below).
- Pancreatitis: Severe pain in your abdomen or back that will not go away.
- Acute gallbladder disease: Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting.
- Hepatitis: Elevated liver enzymes/Jaundice.
- Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy.
- Severe gastrointestinal disease: may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease.